发布求助
文献互助 智能选刊 最新文献

Lakartidningen最新文献

筛选
英文 中文
[Severe asthma and biological therapies]. [严重哮喘和生物治疗]。
Lakartidningen Pub Date : 2025-05-15
Oksana Tenselius, Sara Barsch-Cornacchini, Valentyna Yasinska
{"title":"[Severe asthma and biological therapies].","authors":"Oksana Tenselius, Sara Barsch-Cornacchini, Valentyna Yasinska","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Severe asthma is a relatively common, chronic, heterogeneous inflammatory disease affecting around 4-10% of all asthmatics. Most of these have uncontrolled eosinophilic asthma, the treatment of which accounts for >50% of healthcare costs attributed to the disease. Management of severe asthma requires a thorough investigation to exclude comorbidities and determine the underlying type of inflammation and resulting asthma phenotype, so that suitable treatments can be chosen. Systematic assessment and evaluation of treatment must then be performed every 3-6 months. Severe asthma is mostly driven by type 2 inflammation, and we now have several specific biological therapies targeting this inflammation, yet some patients remain poorly controlled due to the heterogenous nature of this disease with its many sub-phenotypes. Therefore, research must determine which clinical and patient reported outcomes as well as biomarkers best reflect response to therapy and thus should be monitored in the clinic.</p>","PeriodicalId":17988,"journal":{"name":"Lakartidningen","volume":"122 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144078920","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The immunopathology of asthma]. [哮喘的免疫病理]。
Lakartidningen Pub Date : 2025-05-15
Jenny Mjösberg, Johanna Emgård
{"title":"[The immunopathology of asthma].","authors":"Jenny Mjösberg, Johanna Emgård","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Type 2 (T2) high asthma, characterized by T2 markers such as eosinophilia, is driven by type 2 innate lymphoid cells (ILC2) and allergen-activated T helper (Th2) cells. Epithelial-derived cytokines called alarmins, IL-33, TSLP, IL-25 and TL1A, acting on dendritic cells and ILC2, are key in driving both allergic and non-allergic T2 high asthma. Alarmins are produced in response to allergens, pathogens, pollutants etc. Cytokines produced by Th2 cells and ILC2 cause the immunopathology of asthma including eosinophilia, mast cell activation, goblet cell hyperplasia and fibrosis, which in turn causes airway hyperresponsiveness, bronchoconstriction, tissue remodeling and mucus hypersecretion. However, asthma also occurs in patients devoid of T2 markers. The immunological mechanisms of so called T2 low asthma seems to be related to IL-22/IL-17 cytokines and/or inflammasome activation, but much research remains to unravel the etiology and mechanisms to identify ways of effectively treating T2 low asthma.</p>","PeriodicalId":17988,"journal":{"name":"Lakartidningen","volume":"122 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144078922","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Transitional care for adolescents and young adults]. [青少年和年轻人的过渡性护理]。
Lakartidningen Pub Date : 2025-05-15
Inger Kull, Maria Ödling
{"title":"[Transitional care for adolescents and young adults].","authors":"Inger Kull, Maria Ödling","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Research has highlighted the complexities in transitional care for adolescents and young adults, including decreased healthcare contacts and dispensed medication after transfer to adult healthcare. A survey of healthcare professionals revealed that more than half do not adhere to key messages in existing national guidelines and focus more on the transfer process rather than on the transition to independent adulthood. To address the complexities in the transitional care for adolescents and young adults with asthma, there is a need for a comprehensive transition program applicable in both primary and specialist care settings, utilizing a multi-professional approach to gradually strengthen the young person's self-care skills and prepare them for adult healthcare. To bridge the gap in transitional care and improve long-term outcomes for adolescents and young adults with asthma, a pilot study is ongoing in the Stockholm region, with hopes for national implementation.</p>","PeriodicalId":17988,"journal":{"name":"Lakartidningen","volume":"122 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144078924","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Asthma in primary care]. [初级保健中的哮喘]。
Lakartidningen Pub Date : 2025-05-15
Hanna Sandelowsky, Björn Ställberg
{"title":"[Asthma in primary care].","authors":"Hanna Sandelowsky, Björn Ställberg","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Primary care is responsible for diagnostics and follow-up of the majority of patients with asthma. The variable airway obstruction may contribute to difficulties in diagnosing asthma. The cornerstones of diagnostics are patient history and lung function measurements. Even patients with only sporadic symptoms should be treated with inhaled corticosteroids (Step 1 in the asthma treatment track). Patient education is essential for good asthma control. Optimal asthma control means normal lung function, absence of symptoms and absence of exacerbations. This must always be assessed at a patient consultation. In uncontrolled asthma, treatment barriers such as inadequate inhalation technique, insufficient adherence to treatment, exposure to asthma triggers, and possible influence of co-morbidity should be assessed.</p>","PeriodicalId":17988,"journal":{"name":"Lakartidningen","volume":"122 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144078915","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Pulmonary function testing in asthma]. [哮喘的肺功能检查]。
Lakartidningen Pub Date : 2025-05-15
Andrei Malinovschi, Sanna Kjellberg, Kerstin Romberg, Per Wollmer
{"title":"[Pulmonary function testing in asthma].","authors":"Andrei Malinovschi, Sanna Kjellberg, Kerstin Romberg, Per Wollmer","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Spirometry with bronchodilator test is the most frequently used test for asthma diagnosis.  PEF variability can prove variable airflow obstruction when asthma was not confirmed by spirometry with bronchodilator test. Bronchial challenge tests can demonstrate airway hyperresponsiveness.  Measuring exhaled nitric oxide received increased support in the recent asthma diagnosis guidelines. Peripheral airways involvement is common in asthma, can occur despite normal spirometry and be identified by oscillometry and nitrogen gas washout. It is important to continue investigation even if a certain diagnostic test shows negative results when the clinical asthma suspicion persists.</p>","PeriodicalId":17988,"journal":{"name":"Lakartidningen","volume":"122 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144078918","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Asthma prevalence and risk factor patterns]. [哮喘患病率和风险因素模式]。
Lakartidningen Pub Date : 2025-05-14
Anne Lindberg, Helena Backman
{"title":"[Asthma prevalence and risk factor patterns].","authors":"Anne Lindberg, Helena Backman","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Asthma is one of the most common non-communicable chronic diseases in the world, with a prevalence that historically has increased and now seems to have plateaued at around 10 percent of the general population in high-income countries like Sweden. Some phenotypes, especially the allergic asthma, may however still be increasing. Remission is common in children but less common in adults. Future urbanization and changes in lifestyle may lead to increased asthma prevalence, while further improvements in air quality, treatment and care may lead to decreases and benefit those already affected. It is important that we continuously follow trends in asthma prevalence, incidence, remission and risk factor patterns.</p>","PeriodicalId":17988,"journal":{"name":"Lakartidningen","volume":"122 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143971249","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[HPV screening coverage and cancer]. [HPV筛查覆盖率和癌症]。
Lakartidningen Pub Date : 2025-05-13
Joakim Dillner, Penelope Gray
{"title":"[HPV screening coverage and cancer].","authors":"Joakim Dillner, Penelope Gray","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The incidence of cervical cancer after a normal cytology test has been increasing, and now women with a normal cytology have a cancer risk almost as high as the general population. The incidence of cervical cancer after a negative HPV test is about 7 times lower than after a normal cytology test. The 2015 Swedish national screening program recommended HPV screening for women aged 30-70, but some regions did not start implementing HPV screening until 2021. Conceivably, high cancer risks after normal cytology could be explained if women with a recent normal cytology have not been offered HPV screening. The regional HPV test coverage varies between 62% and 89%, with higher coverage linked to lower cancer incidence (r=-0.50; p=0.022). Efforts to increase the coverage of HPV screening as soon as possible are advisable for imminent control of cervical cancer.</p>","PeriodicalId":17988,"journal":{"name":"Lakartidningen","volume":"122 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144028851","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[SRQ - a solution for quality control, clinical decision support and research in rheumatology]. [SRQ——风湿病学质量控制、临床决策支持和研究的解决方案]。
Lakartidningen Pub Date : 2025-05-07
Liselotte Tidblad, Johan Askling, Ewa Berglin, Lena Karlberg, Tor Olofsson, Lotta Ljung
{"title":"[SRQ - a solution for quality control, clinical decision support and research in rheumatology].","authors":"Liselotte Tidblad, Johan Askling, Ewa Berglin, Lena Karlberg, Tor Olofsson, Lotta Ljung","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>SRQ is a nationwide quality registry with information on disease activity and treatment of patients with rheumatic diseases. The purpose is to continuously improve the clinical management and follow-up of rheumatic diseases. Patient-reported outcome measures (PROM) are adapted to the specific rheumatic diseases and represent an important part of the description of the RA disease activity and treatment outcomes. Results from SRQ are presented for each rheumatology unit in quarterly reports. There are also several interactive reports available on the websites srq.nu and »Vården i siffror«. Data from SRQ, often combined with other national registries, form the basis for a large number of research projects.</p>","PeriodicalId":17988,"journal":{"name":"Lakartidningen","volume":"122 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144024165","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mödradödligheten i världen faller men framstegen hotas.
Lakartidningen Pub Date : 2025-05-06
Jerker Liljestrand, Susanne Rautiainen Lagerström, Anna Af Ugglas
{"title":"Mödradödligheten i världen faller men framstegen hotas.","authors":"Jerker Liljestrand, Susanne Rautiainen Lagerström, Anna Af Ugglas","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":17988,"journal":{"name":"Lakartidningen","volume":"122 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144024624","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Treatment options in carcinoid heart disease]. [类癌性心脏病的治疗方案]。
Lakartidningen Pub Date : 2025-05-02
Rickard Lindblom, Staffan Welin, Johan Forsblad, Anders Holmström, Azad Amin, Johannes Bergsten, Anders Albåge
{"title":"[Treatment options in carcinoid heart disease].","authors":"Rickard Lindblom, Staffan Welin, Johan Forsblad, Anders Holmström, Azad Amin, Johannes Bergsten, Anders Albåge","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Neuroendocrine tumours (NET) constitute a heterogenous population of malignancies most often originating from the gastrointestinal tract. NETs cause substantial morbidity, both from local growth and from their ability to produce hormones that affect systemic physiology. About 20% of patients with metastatic NET disease and carcinoid syndrome develop carcinoid heart disease, a condition dominated by primarily right-sided heart failure caused by structural deterioration of the tricuspid and pulmonary valves. Ultimately, valve replacement may be indicated and has been shown to reduce heart failure symptoms and increase long-term survival. Bioprostheses are the valves of choice but have been shown to degenerate early in some patients due to chronic tumour-associated hormonal activity. New transcatheter treatment options are emerging, both as valve-in-valve procedures but potentially also as primary interventions, both in the tricuspid and pulmonary valve position.</p>","PeriodicalId":17988,"journal":{"name":"Lakartidningen","volume":"122 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-05-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144027504","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信